A variety of PPAR ligands have been discovered, and though they are known to play a role in metabolic disorders such as type 2 diabetes and dyslipidemia, research on their new therapeutic potential is ongoing because of their vast influence on human health. This evidence concerns the gene PPARA and metabolic syndrome.